20-(3-(TERT-BUTOXY)-3-OXOPROPYL)-43,43-DIMETHYL-10,19,22,41-TETRAOXO-3,6,12,15,42-PENTAOXA-9,18,21-TRIAZATETRATETRACONTANOIC ACID, (S)-
UNII J2L9X98LQ4
Substance Identification & Data
This profile provides standardized clinical and technical data for 20-(3-(tert-butoxy)-3-oxopropyl)-43,43-dimethyl-10,19,22,41-tetraoxo-3,6,12,15,42-pentaoxa-9,18,21-triazatetratetracontanoic Acid, (s)-, uniquely identified by the FDA Unique Ingredient Identifier (UNII) J2L9X98LQ4.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number N/A and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C45H83N3O13 CTWNVMLIRUGKHO-QNGWXLTQSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for 20-(3-(tert-butoxy)-3-oxopropyl)-43,43-dimethyl-10,19,22,41-tetraoxo-3,6,12,15,42-pentaoxa-9,18,21-triazatetratetracontanoic Acid, (s)-. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.